Arena Pharma (ARNA) Shares See Profit Taking Following Strong Session
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Arena Pharma (NASDAQ: ARNA) shares are down over 6 percent today with volume following a 13 percent gain on Thursday's trading session. Volume is already around double the trailing daily average.
Earlier this week, FBR started coverage on Arena with an Outperform rating and $6 price target. For more color, click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Arena Pharmaceuticals Completes Enrollment in Ralinepag Phase 2 Clinical Trial for Pulmonary Arterial Hypertension (PAH)
- Honeywell (HON) December calls swept up
- Volatility and Volume movement
Create E-mail Alert Related CategoriesTrader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!